Lantheus’ $8 Billion Curium Merger Expands Radiopharmaceutical Reach Across 70 Countries
Lantheus’ proposed Curium merger would create an $8 billion radiopharmaceutical company serving oncology, neurology and cardiology in more than 70 countries.
SUPN and INDV Jump as All-Stock Merger Creates Larger CNS Biopharma Company
SUPN and INDV jumped after announcing a tax-free, all-stock merger of equals aimed at creating a scaled CNS biopharmaceu…
KKR’s $5.7 Billion Integer Buyout Sets $127 Cash Target for ITGR Investors
KKR’s proposed $5.7 billion acquisition of Integer offers ITGR holders $127 per share in cash and highlights private equ…
PayPal Takeover Speculation Puts PYPL Traders on Alert
M&A chatter around Nasdaq-listed PayPal may sharpen trader focus on PYPL volume and options activity, but no bidder or d…
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.